Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Symposia

A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology)

ea0063s6.1 | A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology) | ECE2019

Prediction of the thyroid axis set-point

Medici Marco

In the last few years studies have shown that subtle variations in thyroid function, including subclinical thyroid dysfunction, and even variation in thyroid function within the normal range, are associated with morbidity and mortality. It is estimated that 40–65% of the inter-individual variation in serum TSH and FT4 levels is determined by genetic factors. To identify these factors, various linkage and candidate gene studies have been performed in the past, which have i...

ea0063s6.2 | A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology) | ECE2019

Subclinical hypothyroidism in children

Salerno Mariacarolina

Subclinical hypothyroidism (SH) is a biochemical condition defined by increased TSH serum concentration above the normal range associated with normal concentrations of T4 and Free T4. In children SH is often a benign and remitting condition, for which risk of progression to overt hypothyroidism depends on the underlying cause (i.e. autoimmune SH is associated with an increased risk whereas non–autoimmune with a low risk of progression to overt hypothyroidism). The major c...

ea0063s6.3 | A better life with thyroid hormone (Endorsed by the European Journal of Endocrinology) | ECE2019

Subclinical hypothyroidism in the elderly

Razvi Salman

Background: Both overt hypothyroidism as well as subclinical hypothyroidism is frequently encountered in older individuals. It is increasingly being recognised that treatment of subclinical hypothyroidism may not be beneficial, particularly in an older person. These findings are particularly relevant at a time when treatment with thyroid hormones is increasing and more than 10–15% of people aged over 80 years are prescribed levothyroxine therapy.Mai...